Senseonics Holdings, Inc.
Key Metrics
- Previous Close
- $10.16
- 52-Week Range
- $4.79 – $13.98
- Market Cap
- $533.56M
- P/E (TTM)
- —
- EPS (TTM)
- -2.18
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 6.87
- PEG Ratio
- —
- Return on Equity
- -157.32%
- Return on Assets
- -49.85%
- Gross Margin
- 58.72%
- Operating Margin
- -200.99%
- Profit Margin
- -204.19%
- Current Ratio
- 5.92
- Debt/Equity
- 0.81
- Total Debt
- $62.52M
- Free Cash Flow
- $-71.78M
- Revenue Growth
- 141.60%
- Earnings Growth
- —
- Enterprise Value
- $469.78M
Market Snapshot
About
Senseonics Holdings, Inc. is a medical technology company focused on developing and commercializing continuous glucose monitoring systems for people with diabetes. The company produces the Eversense implantable CGM system, which provides long-term glucose monitoring through a small sensor placed under the skin. Senseonics aims to improve diabetes management through innovative sensor technology.